PL2255799T3 - Środek do zwalczania ubocznych działań chemioterapii raka - Google Patents
Środek do zwalczania ubocznych działań chemioterapii rakaInfo
- Publication number
- PL2255799T3 PL2255799T3 PL10004550T PL10004550T PL2255799T3 PL 2255799 T3 PL2255799 T3 PL 2255799T3 PL 10004550 T PL10004550 T PL 10004550T PL 10004550 T PL10004550 T PL 10004550T PL 2255799 T3 PL2255799 T3 PL 2255799T3
- Authority
- PL
- Poland
- Prior art keywords
- combating
- agent
- side effects
- cancer chemotherapy
- chemotherapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102009020314A DE102009020314A1 (de) | 2009-04-30 | 2009-04-30 | Mittel zur Bekämpfung von Nebenwirkungen der Krebs-Chemotherapie |
EP10004550A EP2255799B1 (de) | 2009-04-30 | 2010-04-30 | Mittel zur Bekämpfung von Nebenwirkungen der Krebs-Chemotherapie |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2255799T3 true PL2255799T3 (pl) | 2012-10-31 |
Family
ID=42729435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10004550T PL2255799T3 (pl) | 2009-04-30 | 2010-04-30 | Środek do zwalczania ubocznych działań chemioterapii raka |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2255799B1 (pl) |
DE (1) | DE102009020314A1 (pl) |
DK (1) | DK2255799T3 (pl) |
ES (1) | ES2387550T3 (pl) |
PL (1) | PL2255799T3 (pl) |
PT (1) | PT2255799E (pl) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2201942A1 (de) * | 2008-12-23 | 2010-06-30 | Intendis GmbH | Zusammensetzung mit Hanföl für die Behandlung topischer Erkrankungen |
-
2009
- 2009-04-30 DE DE102009020314A patent/DE102009020314A1/de not_active Withdrawn
-
2010
- 2010-04-30 DK DK10004550.9T patent/DK2255799T3/da active
- 2010-04-30 PT PT10004550T patent/PT2255799E/pt unknown
- 2010-04-30 ES ES10004550T patent/ES2387550T3/es active Active
- 2010-04-30 EP EP10004550A patent/EP2255799B1/de not_active Not-in-force
- 2010-04-30 PL PL10004550T patent/PL2255799T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
DK2255799T3 (da) | 2012-08-27 |
EP2255799A1 (de) | 2010-12-01 |
ES2387550T3 (es) | 2012-09-26 |
DE102009020314A1 (de) | 2010-11-04 |
PT2255799E (pt) | 2012-08-16 |
EP2255799B1 (de) | 2012-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1245114A1 (zh) | 癌症的抑制 | |
EP2239264A4 (en) | ANTITUMOR AGENT | |
EP2127671A4 (en) | THERAPEUTIC AGENT AGAINST CANCER | |
EP2162149A4 (en) | VACCINE FOR THE PREVENTION OF THE RECHUTE OF BREAST CANCER | |
HK1151734A1 (en) | Therapeutic for hepatic cancer | |
EP2586443A4 (en) | ANTICANCER AGENT USING COMPOUNDS HAVING COMBINED KINASE INHIBITING EFFECT | |
EP2241332A4 (en) | THERAPEUTIC AGENT AGAINST PRITURE | |
GB201016139D0 (en) | Cancer phosholipidome | |
IL202718A0 (en) | Preventive/remedy for cancer | |
IL264349B1 (en) | Regimens containing neratinib for the treatment of cancer | |
HK1223028A1 (zh) | 預防乳腺癌復發的疫苗 | |
EP2407165A4 (en) | ANTIOXIDANTS | |
HK1141236A1 (en) | Potentiation of cancer chemotherapy | |
SI2605764T1 (sl) | Sestavki za zdravljenje raka | |
EP2283862A4 (en) | CANCER AGENT | |
EP2617416A4 (en) | MEANS TO INCREASE CANCER THERAPY | |
GB0918722D0 (en) | Anti cancer agent | |
ZA201103627B (en) | Prophylactic/therapeutic agent for cancer | |
EP2733140A4 (en) | INDIRUBIN DERIVATIVE HAVING HIGHLY SELECTIVE CYTOTOXICITY FOR MALIGNANT TUMORS | |
EP2565192A4 (en) | CANCER AGENT | |
EP2450352A4 (en) | PROPHYLACTIC OR THERAPEUTIC ACTIVE AGAINST CANCER | |
EP2609927A4 (en) | CELL PROTECTION PRODUCTS | |
EP2486929A4 (en) | ANTI-TUMOR THERAPEUTIC AGENT | |
EP2502627A4 (en) | ANTI CANCER AGENTS | |
AP2011005893A0 (en) | Thia-triaza-cyclopentazulenes as P13-kinases inhibitors for the treatment of cancer. |